Toll Free: (877) 796-6397 -- USA and Canada only -- |
Fax: +1-832-582-8590 Orders: +1-832-582-8158 |
Tech Support: +1-832-582-8158 Ext:3 Please provide your Order Number in the email. |
Formula | C25H24N4O2 |
|||
Molecular Weight | 412.48 | CAS No. | 1094614-84-2 | |
Solubility (25°C)* | In vitro | DMSO | 43 mg/mL (104.24 mM) | |
Ethanol | 3 mg/mL (7.27 mM) | |||
Water | Insoluble | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.) |
Description | BIX02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM, and does not inhibit closely related kinases MEK1, MEK2, ERK2, and JNK2. | ||
---|---|---|---|
Targets |
|
||
In vitro | BIX02188 significantly blocks MEK5 catalytic activity with IC50 of 4.3 nM and inhibits ERK5 catalytic activity with IC50 of 0.83 μM. It shows no activity against closely related kinases MEK1, MEK2, ERK1, p38α, JNK2, TGFβR1, EGFR, and STK16 with IC50 values of 1.8 μM for TGFβR1, 3.9 μM for p38α, and >6.3 μM for other kinases. Pretreatment with BIX02188 inhibits sorbitol-induced phosphorylation of ERK5 in HeLa cells in a dose dependent manner and displays no inhibitory activity against the phosphorylation of ERK1/2, p38, and JNK1/2 MAPKs. BIX02188 treatment alone for 24 hours in HeLa or HEK293 cells does not show any cytotoxic effect. BIX02188 inhibits transcriptional activation of MEF2C through the MEK5/ERK5 signaling cascade in active MEK5/ERK5/MEF2C-driven luciferase expression system in HeLa and HEK293 cells with IC50 values of 1.15 μM and 0.82 μM, respectively. [1] BIX02188 also inhibits phosphorylation of BMK1 in bovine lung microvascular endothelial cells (BLMECs) which are stimulated with 300 μM H2O2, in a dose-dependent manner, with IC50 of 0.8 μM, specifically by blocking the MEK5 signal pathway. BIX02188 completely reverses the inhibitory effect on TNF-mediation; JNK activation had a similar effect on BMK1 inhibition, suggesting that it inhibits TNF signaling through activation of the MEK5-BMK1 signaling pathway. [2] |
Kinase Assay:[1] |
|
---|---|
Cell Assay:[1] |
|
|
Data from [Exp Neurol, 2012, 238(2), 209-17]
Data from [Data independently produced by , , J Leukoc Biol, 2016, 99(1):143-52]
MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists [ Cell Death Dis, 2023, 14(11):715] | PubMed: 37919293 |
MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists [ Cell Death Dis, 2023, 10.1038/s41419-023-06229-6] | PubMed: 37919293 |
Non-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell Function [ Cell Stem Cell, 2021, 28(2):257-272.e11] | PubMed: 33091368 |
ERK5 Inhibition Induces Autophagy-Mediated Cancer Cell Death by Activating ER Stress [ Front Cell Dev Biol, 2021, 9:742049] | PubMed: 34805151 |
Tumor-derived exosomes antagonize innate antiviral immunity. [ Nat Immunol, 2018, 19(3):233-245] | PubMed: 29358709 |
Dual role of ERK5 in the regulation of T cell receptor expression at the T cell surface [Rovira-Clavé X, et al. J Leukoc Biol, 2016, 99(1):143-52] | PubMed: 26302753 |
BAFF activation of the ERK5 MAP kinase pathway regulates B cell survival. [ J Exp Med, 2015, 212(6):883-92] | PubMed: 25987726 |
Erk5 inhibits endothelialmigration via KLF2-dependent down regulation of PAK1 [Komaravolu RK, et al. Cardiovasc Res, 2015, 105(1):86-95] | PubMed: 25388666 |
Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1. [Komaravolu RK, et al. Cardiovasc Res, 2015, 105(1):86-95] | PubMed: 25388666 |
Increased IGF-IEc expression and mechano-growth factor production in intestinal muscle of fibrostenotic Crohn's disease and smooth muscle hypertrophy [ Am J Physiol Gastrointest Liver Physiol, 2015, 309(11):G888-99] | PubMed: 26428636 |
RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.
NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.